Cobicistat + Elvitegravir + Emtricitabine + Tenofovir

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Cobicistat cobicistat
Elvitegravir elvitegravir
Emtricitabine emtricitabine
Tenofovir tenofovir

Brands with this exact combination

Brand	Composition & strength	Manufacturer
GENVOYA 150 mg/150 mg/200 mg/10 mg, comprimé pelliculéFR	tablet Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir 11.2 mg	GILEAD SCIENCES IRELAND UC (IRLANDE)
STRIBILD 150 mg/150 mg/200 mg/245 mg, comprimé pelliculéFR	tablet Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir 300 mg	GILEAD SCIENCES IRELAND UC (IRLANDE)

Same combination in other markets

Cross-market comparison is not available for this grouped name.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.